Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4. (2023)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41467-023-37811-3
PubMed Identifier: 37185332
Publication URI: http://europepmc.org/abstract/MED/37185332
Type: Journal Article/Review
Volume: 14
Parent Publication: Nature communications
Issue: 1
ISSN: 2041-1723